Patents by Inventor Peter R. Martin

Peter R. Martin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10380905
    Abstract: A network device includes a memory, a display, a user interface, and a network communication module configured to receive vehicle data, driver information, and driver communications, at pre-determined times, from a plurality of portable wireless data transfer and display devices via a long-range wireless network. The network communication module is further configured to send and receive network communications with one or more of the portable wireless data transfer and display devices via the long-range wireless network. The network device is configured to present the vehicle data, the driver information, the driver communication, and the network communications from the plurality of portable wireless data transfer and display devices via the display. The user interface is configured to allow for selection of the drivers presented and is configured to accept user inputs of network communications via the user interface.
    Type: Grant
    Filed: December 28, 2012
    Date of Patent: August 13, 2019
    Assignee: XRS CORPORATION
    Inventors: Charles Mohn, Christopher A. Sekula, Sarat Kakumanu, Odell R. Tuttle, Daniel P. Fuglewicz, Peter S. Anderson, Thomas J. Martin, Jr.
  • Publication number: 20030013758
    Abstract: This invention describes the novel use of alkyl, alkoxyl, halogenyl, or hydroxy substituted dicinnamoylquinides as therapeutic agents for enhancing adenosine levels in the brain and peripheral organs. These agents are particularly useful in treating human diseases or conditions that benefit from acute or chronic elevated levels of adenosine, such as reperfusion injury, coronary or cerebral ischemia, coronary vasoconstriction, paroxysmal supraventricular tachycardia, hypertension, wound healing, diabetes, inflammation, or sleep disturbances. They can also be used to protect normal cells from chemotoxicity in patients undergoing cancer therapy, and reverse the behavioral effects of caffeine intake.
    Type: Application
    Filed: May 10, 2002
    Publication date: January 16, 2003
    Inventors: Tomas de Paulis, David M. Lovinger, Peter R. Martin
  • Patent number: 4219532
    Abstract: A foaming device including a housing with a cylindrical passage therethrough and four housing ports which provide communication between exterior and interior of the housing, the housing ports being connected to sources of fluids; a cylindrical spool slidably disposed within the housing provided with an axial passage therethrough and three spool ports in communication with the spool passage; the spool being displaceable to on, off and cleaning positions in a way that one has to go through the cleaning position when displacing the spool from the on to off position or vice versa.
    Type: Grant
    Filed: October 10, 1978
    Date of Patent: August 26, 1980
    Assignee: Borden, Inc.
    Inventors: Clifford H. Messervey, Peter R. Martin